Exact Mass: 301.0791

Exact Mass Matches: 301.0791

Found 28 metabolites which its exact mass value is equals to given mass value 301.0791, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

4-Nitrophenyl β-D-galactopyranoside

4-Nitrophenol-alpha-D-galactopyranoside

C12H15NO8 (301.0798)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   

2-Nitrophenyl a-D-galactopyranoside

2-(hydroxymethyl)-6-(2-nitrophenoxy)oxane-3,4,5-triol

C12H15NO8 (301.0798)


   

4-Nitrophenyl beta-D-glucopyranoside

2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol

C12H15NO8 (301.0798)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   
   

4-Hydroxypyridyl-3-oic acid 4-O-glucopyranoside|4-hydroxypyridyn-3-oic acid 4-O-glucopyranoside

4-Hydroxypyridyl-3-oic acid 4-O-glucopyranoside|4-hydroxypyridyn-3-oic acid 4-O-glucopyranoside

C12H15NO8 (301.0798)


   

7-chloro-5-(2-fluorophenyl)-N-methyl-3H-1,4-benzodiazepin-2-amine

7-chloro-5-(2-fluorophenyl)-N-methyl-3H-1,4-benzodiazepin-2-amine

C16H13ClFN3 (301.0782)


   

4-Nitrophenyl α-D-mannopyranoside

4-Nitrophenyl α-D-mannopyranoside

C12H15NO8 (301.0798)


   

3-Nitrophenyl b-D-galactopyranoside

3-Nitrophenyl b-D-galactopyranoside

C12H15NO8 (301.0798)


   

4-nitrophenyl α-D-glucoside

4-Nitrophenyl alpha-D-glucopyranoside

C12H15NO8 (301.0798)


   

(2R,3S,4S,5R,6S)-2-(HYDROXYMETHYL)-6-(3-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

(2R,3S,4S,5R,6S)-2-(HYDROXYMETHYL)-6-(3-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

C12H15NO8 (301.0798)


   

4-nitrophenyl-beta-D-mannopyranoside

4-nitrophenyl-beta-D-mannopyranoside

C12H15NO8 (301.0798)


   

3-Nitrophenyl alpha-D-galactopyranoside

3-NITROPHENYL-ALPHA-D-GALACTOPYRANOSIDE

C12H15NO8 (301.0798)


   

4-Nitrophenyl α-D-galactopyranoside

4-nitrophenyl-alpha-D-galactopyranoside

C12H15NO8 (301.0798)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   

PNPG

4-Nitrophenyl beta-D-glucopyranoside

C12H15NO8 (301.0798)


   

4-METHOXY-3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID

4-METHOXY-3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID

C11H16BNO6S (301.0791)


   

2-Nitrophenyl β-D-glucopyranoside

2-Nitrophenyl beta-D-glucopyranoside

C12H15NO8 (301.0798)


   

Pramipexole dihydrochloride hydrate

Pramipexole dihydrochloride monohydrate

C10H21Cl2N3OS (301.0782)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D020011 - Protective Agents > D000975 - Antioxidants Pramipexole dihydrochloride hydrate is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride hydrate can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].

   

P-NITROPHENYL B-D-GALACTOFURANOSIDE

4-nitrophenyl beta-D-galactofuranoside

C12H15NO8 (301.0798)


   

(4-Methoxy-3-(Morpholinosulfonyl)phenyl)boronic acid

(4-Methoxy-3-(Morpholinosulfonyl)phenyl)boronic acid

C11H16BNO6S (301.0791)


   

ONPG

2-Nitrophenyl-beta-D-galactopyranoside

C12H15NO8 (301.0798)


   

2-Nitrophenyl α-D-galactopyranoside

2-Nitrophenyl α-D-galactopyranoside

C12H15NO8 (301.0798)


   

4-Nitrophenylbeta-D-galactopyranoside

4-Nitrophenylbeta-D-galactopyranoside

C12H15NO8 (301.0798)


   

(R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate

(R)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride hydrate

C10H21Cl2N3OS (301.0782)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D020011 - Protective Agents > D000975 - Antioxidants

   

2-Nitrophenylgalactoside

2-Nitrophenylgalactoside

C12H15NO8 (301.0798)


   

o-Nitrophenyl-beta-D-galactopyranoside

o-Nitrophenyl-beta-D-galactopyranoside

C12H15NO8 (301.0798)


   

4-hydroxypyridyl-3-oicacid 4-o-glucopyrano-side

NA

C12H15NO8 (301.0798)


{"Ingredient_id": "HBIN010571","Ingredient_name": "4-hydroxypyridyl-3-oicacid 4-o-glucopyrano-side","Alias": "NA","Ingredient_formula": "C12H15NO8","Ingredient_Smile": "C1=CN=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyridine-3-carboxylic acid

4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyridine-3-carboxylic acid

C12H15NO8 (301.0798)


   

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyridine-3-carboxylic acid

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyridine-3-carboxylic acid

C12H15NO8 (301.0798)